Download PDF
Thromb Haemost 1996; 76(03): 477-478
DOI: 10.1055/s-0038-1650604
Letters to the Editor
Schattauer GmbH Stuttgart

Oral Contraceptives Are a Risk Factor for Cerebral Vein Thrombosis

I Martinelli
1   The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy
,
F R Rosendaal
2   The Dept of Clinical Epidemiology, Leiden University Hospital, Leiden, The Netherlands
,
J P Vandenbroucke
2   The Dept of Clinical Epidemiology, Leiden University Hospital, Leiden, The Netherlands
,
P M Mannucci
1   The Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milan, Italy
› Author Affiliations
Further Information

Publication History

Received 29 May 1996

Accepted 30 May 1996

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Martinelli I, Landi G, Merati G, Celia E, Tosetto A, Mannucci PM. Factor V gene mutation is a risk factor for cerebral vein thrombosis. Thromb Haemost 1996; 75: 393-394
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaalb FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457
    CrossrefPubMedGoogle Scholar
  • 3 Rosendaal FR. Oral contraceptives and screening for factor V Leiden. Thromb Haemost 1996; 75: 524-525
    Article in Thieme ConnectPubMedGoogle Scholar